直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Warner-Lambert Company LLC v. Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Warner-Lambert Company LLC v. Sandoz GmbH*

Warner-Lambert Company LLC

Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH

Represented Pfizer group Warner-Lambert in enforcing its second medical use patent for blockbuster drug Lyrica® (pregabalin) as a neuropathic pain treatment against numerous generic companies in the UK and across Europe. Heralded as the IP case of the decade in the UK, it was heard in the Supreme Court in 2018 (having previously been before the Court of Appeal twice) on the most difficult issues in English patent law namely plausibility and infringement of second medical use patents.

Warner-Lambert Company LLC v. Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH, [2015] EWHC 485 (Pat); Claim number: HC-2014-001795; [2015] EWHC 2548 (Pat); Claim numbers: HP-2014-000035, HP-2014-000021, and HC-2014-001795; [2015] EWHC 3153 (Pat); Claim number: HP-2015-000049; [2015] EWHC 3370 (Pat); Claim numbers: HP-2014-000035, HP-2014-000021, and HC-2014-001795; [2016] EWHC 3317 (Pat); Claim number: HP-2015-000049, Patents Court, Judge Arnold

Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH v. Warner-Lambert Company LLC, [2015] EWCA Civ 556; Appeal numbers: A3/2015/0221 and A3/2015/0669, Court of Appeal, Judges Arden, Ryder, Floyd

Warner-Lambert Company LLC v. Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH, [2015] EWHC 2919 (Pat); Claim number: HP-2014-000049; [2015] EWHC 2924 (Pat); Claim number: HP-2014-000049, Patents Court, Judge Birss

Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH v. Warner-Lambert Company LLC, [2016] EWCA Civ 1006; Appeal numbers: A3/2015/3415, A3/2015/3602, A3/2015/3615, and A3/2016/0017, Court of Appeal, Judges Patten, Kitchin, Floyd

Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH v. Warner-Lambert Company LLC, [2018] UKSC 56; Appeal number: UKSC 2016/0197, 2017/0069, and 2017/0078, Supreme Court of the United Kingdom, Judges Mance, Sumption, Reed, Hodge, Briggs

Related Professionals

Jin Ooi
Partner
London
+44 20 7864 2821
Email

Related Practices

Global IP Enforcement, Litigation, and Trials

Patent Litigation and Trials

Related Industries

Life Sciences

Pharmaceutical

Biologics

*Matter handled prior to joining Finnegan.

Related Experiences

Accord Healthcare Limited & Ors v. The Regents of the University of California & Astellas Pharma Europe Ltd.*

The Regents of the University of California & Astellas Pharma Europe Ltd.

Dr Reddy’s Laboratories (UK) Limited v. Boehringer Ingelheim International GmbH*

Boehringer Ingelheim International GmbH

Dr Reddy’s Laboratories (UK) Limited & Ors v. Warner-Lambert Company LLC & Anor*

Warner-Lambert Company LLC & Anor

Dorco Company, Ltd. v. The Gillette Company, LLC

Dorco Company, Ltd.

Assisted leading multinational consumer electronics corporations in successfully obtaining interim licence declarations in high-profile standard essential patent (SEP) disputes*

Teavana Corp. v. The Veda Company, LLC

Teavana Corp.

Bay Materials, LLC v. 3M Company

Bay Materials, LLC

Grünenthal GmbH et al. v. Actavis Elizabeth LLC et al.

Grünenthal GmbH

Startup sold to major drug company based on strength of patents

Agouron Pharmaceuticals, Inc.

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP